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ABSTRACT
Cilia assembly is under strict transcriptional control
during animal development. In vertebrates, a hierar-
chy of transcription factors (TFs) are involved in con-
trolling the specification, differentiation and function
of multiciliated epithelia. RFX TFs play key functions
in the control of ciliogenesis in animals. Whereas
only one RFX factor regulates ciliogenesis in C. el-
egans, several distinct RFX factors have been im-
plicated in this process in vertebrates. However, a
clear understanding of the specific and redundant
functions of different RFX factors in ciliated cells
remains lacking. Using RNA-seq and ChIP-seq ap-
proaches we identified genes regulated directly and
indirectly by RFX1, RFX2 and RFX3 in mouse ependy-
mal cells. We show that these three TFs have both re-
dundant and specific functions in ependymal cells.
Whereas RFX1, RFX2 and RFX3 occupy many shared
genomic loci, only RFX2 and RFX3 play a prominent
and redundant function in the control of motile cili-
ogenesis in mice. Our results provide a valuable list
of candidate ciliary genes. They also reveal stunning
differences between compensatory processes oper-
ating in vivo and ex vivo.
INTRODUCTION
Cilia are highly conserved organelles serving fundamental
functions in eukaryotes. Their assembly is tightly regulated
during the cell cycle and tissue differentiation. For instance,
primary cilia, which are present on many cells during verte-
brate development, are disassembled at the onset of cell di-
vision and reassembled during subsequent cell cycle phases.
During animal development, cilia assembly relies on strict
transcriptional programs that coordinate cilia growth and
tissue morphogenesis (reviewed in (1,2)). This transcrip-
tional regulation has been thoroughly described for the dif-
ferentiation of multi-ciliated epithelia in vertebrates (3,4).
Several key transcription factors (TFs) are involved in this
process. Upstream of the ciliogenesis pathway, two TFs of
the Geminin family, Gemc1 and MCIDAS (or multicilin)
(5,6), directly control centriole amplification, which is re-
quired for the assembly of multiple cilia. Downstream of
these TFs, members of the FOXJ1 (7–10) and RFX families
(11–16) have been shown to be direct regulators of core cil-
iogenic genes in multiciliated cells. In addition, members of
the E2F and MYB families of TFs have been implicated in
multiciliated cell differentiation (17–20). Recently, TAP73
was shown to regulate cilia assembly in mammalian airways
(21–23). These different TFs engage in complex regulatory
interactions, as revealed by specific cross regulatory loops,
although most of these regulatory processes remain poorly
understood.
Whereas, all of the aforementioned ciliogenic transcrip-
tion factors play critical roles in the development of motile
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cilia, only RFX factors are also required for the assembly
of non-motile cilia. Daf-19, the sole member of the RFX
family in Caenorhabditis elegans, was initially shown to reg-
ulate cilia assembly in all ciliated cells of the nematode (24).
In Drosophila melanogaster, one of the two Rfx genes is re-
quired for sensory cilia assembly (25). In vertebrates and
mammals, there are at least 8 different Rfx genes (2,26,27)
several of which were shown to be required for ciliogene-
sis, either broadly, such as RFX3 in mice (11,12,28,29) and
RFX2 in xenopus or zebrafish (13,30), or in specific tissues,
such as RFX2 in multiciliated cells and RFX4 or RFX7 in
the mouse neural tube (31–33).
In addition to their conserved roles in ciliogenesis, RFX
proteins are involved in other processes ranging from the
control of genome integrity and the cell cycle in yeast and
fungi (34,35), to immune functions (36,37), and tissue and
organ differentiation in the mouse or zebrafish (33,38–40).
Several human diseases result from mutations in Rfx genes
(37,38,41).
RFX proteins are characterized by a DNA binding do-
main of the winged-helix type (42) that specifically recog-
nizes an inverted repeat element, the X-box, initially iden-
tified in Major Histocompatibility Complex Class II genes
(36). Several of the RFX proteins also share a dimerization
domain, allowing homo and heterodimerization (26,27,43).
Whereas many RFX target genes have been identified in
various ciliated cell systems (13,44,45), little is known about
how the functional specificity of different RFX factors is
achieved and to what extent they have shared or redundant
roles. To date, none of the studies aiming at identifying RFX
targets has addressed the respective functions of several in-
dividual RFX proteins in the same cell type or tissue.
Here, we investigated the redundant and specific roles
of three members of the RFX family––RFX1, RFX2 and
RFX3––in the differentiation of multi-ciliated cells in mice,
focusing on ependymal cells of the brain ventricle. These
three transcription factors form a phylogenetic subgroup of
highly related proteins, but only RFX2 and/or RFX3 have
been implicated in cilia-associated functions in zebrafish,
xenopus or mammals (2,26,27). Using high throughput
RNA-seq and ChIP-seq approaches, we identified genes
that are regulated directly or indirectly by these three TFs.
We show that RFX1, RFX2 and RFX3 have complex over-
lapping functions and engage in potential regulatory inter-
actions that cannot be explained solely by their binding-site
specificities. Our study also provides valuable predictions of
new ciliary genes. Finally, our results uncover unanticipated
compensatory mechanisms operating in vivo compared to
ex-vivo culture conditions, underlining the complexity of cil-
iary gene regulation in physiological settings.
MATERIALS AND METHODS
Mouse husbandry and genotyping
The generation of Rfx1−/− and Rfx3flox/flox mice was de-
scribed in (11). The generation of Rfx2−/− and Rfx2flox/flox
mice was described in (46). The generation of Rfx1flox/flox
mice was described in (47). After deletion of exon 10 in
Rfx1, splicing of exon 9 to exon 11 leads to a frame
shift. For generation of Rfx1−/− mice, Rfx1flox/flox mice
were crossed with a deleter strain expressing Cre ubiqui-
tously under the control of a cytomegalovirus promoter
(48). For generation of mice having conditional dele-
tions of Rfx genes, mice carrying floxed Rfx alleles were
crossed with FoxJ1-Cre mice. FoxJ1-Cre mice express Cre-
recombinase in all multiciliated cells of the mouse (49). All
mice were in a C57Bl/6 genetic background. Mice were
genotyped using the following primers: Rfx1, TGTCTC
CAGGGTAGGCACAAG and TTCTGTGACTGTGG
GAGACTG; Rfx2, AGAATCTGCCCCTTGGCTAT and
TGTCACCCACCTAGGCTTCT; Rfx3, GTCATGCTGG
AAAATTTGAAG and AGTTGGCTTCTAACTTCTAT
G; FoxJ1, GACCGCCCCCTCGGAGAGTCCC and CC
TGGCAATTTCGGCTATACG.
Scanning electron microscopy
Brains were dissected as previously described (50) and fixed
in 2% glutaraldehyde (Sigma-Aldrich, France), 0.1 M ca-
codylate buffer (EMS, USA), pH 7.4. Brain samples were
then washed several times in 0.2 M cacodylate buffer, pH
7.4 and postfixed for 60 min in 1% OsO4 (EMS, USA), 0.1
M cacodylate buffer. Fixed brain samples were washed ex-
tensively with distilled water and dehydrated in a graded se-
ries of ethanol solutions and finally in acetone. Brain sam-
ples were then prepared for scanning electron microscopy
by the critical point freeze-dry procedure (Leica, EM CPD
300). Samples were surface-coated using a gold/palladium
spattering device (Hummer 2, Technics) under optimal con-
ditions for 5 min and observed with a scanning electron mi-
croscope (ZEISS Merlin Compact) at 5 keV. Observations
were performed at the Centre for Microstructure Analysis
of the University of Lyon.
Cell isolation and preparation
Brains of newborn pups (OF1 strain) were dissected and
processed as described previously (12). After 4 days of
serum deprivation, cells were fixed and processed for ChIP
experiments as described (51). Briefly, 1/10 of fixation
buffer (11% formaldehyde; 0.1 M NaCl; 50 mM HEPES
pH 7.9) was added to cell dishes and cells were fixed at
room temperature for 8 min with gentle rocking. Glycine
was added to 0.18 M (final concentration) and cells were
quickly scraped off on ice. After centrifugation, the cell pel-
let was washed once with cold PBS 1× and conserved at
–80◦C until further analysis. Before use, thawed cells were
washed once with cold PBS and lysed in TE buffer (10 mM
Tris–HCl at pH 8.0, 1 mM EDTA) containing protease in-
hibitors and 0.5% NP-40. Brains from E18.5 Rfx1−/− em-
bryos (four independently processed embryos = four repli-
cates), Rfx2−/− embryos (six replicates), Rfx3−/− embryos
(six replicates) or wild type littermate controls (four, eight,
six embryos, respectively) were dissected and processed as
described (12). After 4 days of serum deprivation, total
RNA was extracted using TRIzol reagent (Thermo Fisher
Scientific).
Immunofluorescence on tracheal and ependymal cells
Brains or tracheas were dissected and fixed in 4%
paraformaldehyde (EMS, USA) overnight at 4◦C. Tissues
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were saturated in 0.2% triton, 10% normal goat serum, 1%
BSA in PBS for at least 1h at RT, before O/N incubation
at 4◦C with a monoclonal antibody (1/150, Sigma T6793)
against mouse acetyl-tubulin in 0.1% triton, 10% normal
goat serum, 1% BSA in PBS to visualize cilia. Samples were
then washed several times in PBS before 2h incubation at
room temperature with secondary goat anti-mouse anti-
bodies labeled with Alexa 488 (Invitrogen, France) and for
5 min in Hoechst. Brains or trachea were mounted in Vec-
tashield and visualized with a Confocal spectral Leica SP5.
For ciliated cell enumeration: ten arbitrary pictures were
taken of different areas of the trachea with a 40× water im-
mersion Confocal spectral Leica SP5 objective. Images were
stacked and ciliated cells were counted using ImageJ soft-
ware.
For analysis of cell specific RFX2 or RFX3 dele-
tion: brains were dissected and fixed in 4% paraformalde-
hyde overnight at 4◦C. Tissues were embedded in sucrose.
12 m cryostat sections were saturated in 0.1% triton,
10% normal goat serum, 1% BSA in PBS for at least
1h at RT, before O/N incubation at 4◦C with RFX3
(Sigma HPA035689) and RFX2 (Sigma HPA048969) anti-
bodies and against mouse acetyl-tubulin antibody (1/150,
Sigma T6793) in 0.1% triton, 10% normal goat serum,
1% BSA in PBS. Samples were then washed several
times in PBS before incubation with secondary goat anti-
mouse Alexa 488 antibody and Alexa 555 anti-rabbit anti-
body (Thermo Fisher, France) and for 5 min in Hoechst.
Brains or trachea were mounted in Vectashield and vi-
sualized with a Confocal spectral Leica SP5. Observa-
tions were performed at the PLATIM of the University
of Lyon.
RNA-seq experiments
Four to eight replicates (see above) were processed for each
condition. cDNA libraries were constructed by the Ge-
nomics platform of the University of Geneva using the Il-
lumina TruSeq RNA Sample Preparation Kit according
to the manufacturer’s protocol. Libraries were sequenced
using single-end 100nt-long reads on Illumina HiSeq2000.
FastQ reads were mapped to the ENSEMBL reference
genome (GRCm38.89) using STAR version 2.4.0j (52) with
standard settings, except that any reads mapping to more
than one location in the genome (ambiguous reads) were
discarded (m = 1). Sequence data has been submitted to
the GEO database under the accession number GSE145324.
A unique gene model was used to quantify reads per gene.
Briefly, the model considers all annotated exons of all anno-
tated protein coding isoforms of a gene to create a unique
gene where the genomic region of all exons are considered
coming from the same RNA molecule and merged together.
All reads overlapping with the exons of each unique gene
model were reported using featureCounts version 1.4.6-p1
(53). Gene expression was reported as raw counts and nor-
malized as reads per kb per million (RPKM) to filter out
genes with low expression values (<1 RPKM) before iden-
tifying differentially expressed genes. Library size normal-
ization and differential gene expression calculations were
performed using the package edgeR (54) designed for the
R software. Only genes having a significant fold-change
(Benjamini–Hochberg corrected P-value < 0.001) were con-
sidered for the rest of the RNAseq analysis.
ChIP-seq experiments
Chromatin was purified from ex vivo derived ependymal
cells from WT mice (OF1 strain). Chromatin immunopre-
cipitation was performed as previously described (46).
Immunoprecipitated DNA was sequenced by the Ge-
nomics platform of the University of Geneva using the
Illumina TruSeq ChIP Library Prep Kit according to
the manufacturer’s protocol. Libraries were sequenced us-
ing single-end 50nt-long reads on Illumina HiSeq2000.
FastQ reads were mapped to the ENSEMBL reference
genome (GRCm38.89) using bowtie version 0.12.7 (55)
with standard settings, except that any reads mapping to
more than one location in the genome (ambiguous reads)
were discarded (m = 1). Duplicate reads were removed
using Samtools version 0.1.18 (56). Sequence data has
been submitted to the GEO database under the acces-
sion number n◦ GSE145324. Fragment length was esti-
mated using cross-correlation (57). The Phantompeakqual-
tools R package (https: //www.encodeproject.org/software/
phantompeakqualtools/) was used to measure the qual-
ity of the ChIPseq data, as assessed by the normalized
ratio between the fragment-length cross-correlation and
the background cross-correlation (normalized strand coef-
ficient, NSC), the ratio between the fragment-length peak
and the read-length peak (relative strand correlation, RSC)
and the Qtag code. Peak calling was done with MACS2 ver-
sion 2.0.10.20130520 (58) with no-model setting and shift-
size parameter set to half of the estimated fragment length.
Peak calling stringency was decreased by using P = 0.05
as threshold and applying the ’-to-large’ setting. Repro-
ducible peaks were obtained by assessing the IDR for all
pairs of replicates. The Fraction of Reads in Peaks (FRiP)
(57) was found to be similar between replicates and corre-
lated positively with the number of peaks. Antibodies used
for ChIPseq are: RFX2 Antibody (C-15): sc-10657, RFX1,
RFX3 mouse antibodies previously described in (28,59).
All three were validated in vivo and in ChiP experiments
(12,46,47,60).
Gene set enrichment analysis
Ciliary gene sets were generated from previously published
data (61,62). Expressed genes included in the Rfx1, Rfx2
and Rfx3 RNA-seq data sets were ranked according to their
fold change in knockout cells relative to WT cells. Gene
set enrichment analysis was then done using the GSEA
package Version 2.2 (63,64) from the Broad Institute (MIT,
Cambridge, MA) for (a) different ciliary gene sets or (b)
RFX1, RFX2 and RFX3 ChIP-seq peaks in promoters.
Gene set permutations were performed 1000 times for each
analysis. The Normalized Enrichment Score (NES) was cal-
culated for each gene set. GSEA results with a nominal
FDR < 0.05 and abs(NES) > 1 were considered significant.
De novo motif discovery and motif enrichment analysis
For analysis of differentially expressed genes, promoter se-
quences (−1000 bp to +500 bp relative to the TSS) were
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extracted, oriented according to gene orientation and used
as input. For analysis of ChIP-seq data, peak sequences
were used as input. De novo motif discovery was done us-
ing the cosmo package (65) designed for R (53). The proba-
bilistic model used for the motif discovery was the zero-or-
one-occurrence-per-sequence (ZOOPS), considering only
the orientation of each promoter and motif lengths be-
tween 10nt and 20nt. Pscan (66) was used to identify over-
represented TF-binding-sites (TFBSs) using the JASPAR
database (67) as matrices. TFBSs with P-values lower than
0.001 were considered to be significantly overrepresented.
The motifs defined by the de novo analysis of ChIP-seq
peaks (Figure 4C) was averaged and used to scan both
strands of gene promoters (−1000/+500) to determine the
presence of a X-box motifs. Results are reported in Figures
2C, 6C and 7 and Supplementary Figure S7.
Gene ontology
GO term enrichment was performed using Panther classifi-
cation tool (68).
RESULTS
Differential phenotypes of Rfx1−/−, Rfx2−/− and Rfx3−/−
mice
We focused our study on three mouse RFX factors––RFX1,
RFX2 and RFX3––exhibiting different patterns of expres-
sion in vivo. Expression of the Rfx1 gene is ubiquitous
and does not exhibit selective enrichment in specific tis-
sues (59,69). In contrast, expression data available in pub-
lic databases reveal that the mouse Rfx2 and Rfx3 genes
are both expressed preferentially in ciliated tissues: whereas
Rfx2 expression is largely restricted to tissues harboring
motile cilia, expression of Rfx3 is more widespread but en-
riched in tissues presenting motile cilia.
In agreement with their differential patterns of expres-
sion, germline deficiencies of the three RFX factors have
different in vivo consequences. We previously reported that
Rfx2−/− and Rfx3−/− mice exhibit different phenotypes
(11,46). Whereas Rfx2−/− mice are viable and develop nor-
mally, showing only fertility defects, Rfx3−/− mice suffer
from severe developmental defects and exhibit major hall-
marks of ciliopathies (11,12,28).
Several different Rfx1−/− mouse models have been re-
ported. In the first model, consisting of a gene trap insertion
into the second exon, Rfx1−/− mice were found to die dur-
ing embryogenesis (70). Two subsequent models were based
on the excision of two exons encoding the DNA binding
domain of RFX1 (37,71). These two independent models
were used to demonstrate that Rfx1 inactivation in the testis
leads to complete male sterility (71) and that Rfx1 inactiva-
tion in T cells leads to increased susceptibility to autoim-
mune disease (37). Finally, we previously reported the gen-
eration of mice harboring a LoxP-flanked (floxed) Rfx1 al-
lele (Rfx1flox), which allows conditional Cre-mediated dele-
tion of exons encoding the DNA binding domain. This dele-
tion furthermore leads to a frame-shift in the protein cod-
ing sequence, thereby removing all downstream regions of
the protein (Supplementary Figure S1A). This conditional
Rfx1 allele was previously used to demonstrate that RFX1
and RFX3 have redundant functions in inner ear develop-
ment (47).
To further investigate the function of RFX1 we investi-
gated the phenotype of Rfx1−/− mice obtained by germline
induced Cre-mediated recombination of the Rfx1flox al-
lele. We observed that newborn (P0) Rfx1−/− pups arose
at the expected Mendelian frequency from Rfx1+/− inter-
crosses and presented no overt growth or developmental
defects. Homozygous Rfx1−/− pups were viable, reached
adulthood and exhibited no obvious defects, although they
did show an increased susceptibility to weaning compared
to Rfx1+/+ and Rfx1+/− littermates (Supplementary Figure
S1B). Adult Rfx1−/− males and females were fertile and
produced litters of comparable size relative to heterozygous
controls (Supplementary Figure S1C). These observations
indicate that, in contrast to previously published observa-
tions, Rfx1 is in our hands dispensable for mouse develop-
ment and survival. Several explanations could account for
this discrepancy. First, acute inactivation induced by condi-
tional deletion might lead to more severe phenotypes than
those induced by constitutive deletion. This could explain
the infertility observed after inactivating Rfx1 specifically
in the testis (71). Second, variable phenotypes could result
from differences in the genetic backgrounds of the mouse
strains. Our model indicates that RFX1 is dispensable for
mouse development in a C57Bl/6J background and under
standard housing conditions.
In agreement with their good survival rates, Rfx1−/−
mice exhibited normal ciliogenesis in the brain ventricles
(Figure 1A) and trachea (Supplementary Figure S2A). As
reported previously (46), a deficiency in RFX2 did not lead
to specific alterations of motile cilia in the brain (Figure 1B).
We had previously reported that Rfx3−/− mice exhibit se-
vere hydrocephalus, which was not attributable to an ob-
servable defect in motile cilia but instead to differentiation
defects in two major tissues required for cerebrospinal fluid
homeostasis, namely the sub-commissural organ and the
choroid plexus (28). As a consequence of these defects, all
Rfx3−/− pups die at birth in a C57Bl/6 background (11). To
overcome this embryonic lethality, and to analyze the brains
of adult mice exhibiting a selective deficiency in RFX3, we
used a conditional knockout approach based on cell-specific
deletion of a floxed Rfx allele (Rfx3flox) by a Foxj1-Cre
transgene (49), which drives Cre-mediated recombination in
cells bearing motile cilia. Effective elimination of RFX3 ex-
pression was verified by immunofluorescence (Supplemen-
tary Figure S2D). RFX3-deficient ependymal cells did not
show ciliated defects in vivo (Figure 1C). In summary, all
three RFX factors are dispensable, individually, for the de-
velopment of multiple cilia on ependymal cells in vivo.
RFX2 and RFX3 are key regulators of ependymal cell cilio-
genesis in vitro and in vivo
To further study the respective roles of RFX1–3 in the devel-
opment of motile cilia, we differentiated ependymal cells in
vitro from ventricular progenitors derived from E18.5 em-
bryos. In agreement with our in vivo data (Figure 1A), ex
vivo differentiated Rfx1−/− ependymal cells did not show
major defects in ciliogenesis: neither the number of cil-
iated cells nor the number of cilia per cell were signifi-
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Figure 1. RFX2 and RFX3 play critical roles in ependymal cell ciliogenesis. (A–C) Lateral ventricles of P15 brains were analyzed by scanning electron
microscopy for Rfx1−/− (A), Rfx2−/− (B) or conditional FoxJ1-Cre;Rfx3flox/flox mice (C). Brains from Rfx1+/+, Rfx2+/+ or FoxJ1-Cre; Rfx3flox/+ mice
were used as controls, respectively. No alterations in the number of ciliated cells or in the number and size of cilia were detected in the mutants. (D–G) In
vitro differentiated ependymal cells derived from lateral brain ventricular progenitors at E18.5. (D) Representative images of multiciliated ependymal cell
cultures at 12 days post serum deprivation stained for acetylated tubulin (green). (E–G) Graphs represent the percentages of multiciliated cells observed
after 5 or 12 days of serum deprivation. No significant differences were observed between control and Rfx1−/− cells (E), whereas strong reductions in the
number of ciliated cells were observed for Rfx2−/− (F) and Rfx3−/− (G) cells. *P < 0.05; ***P < 0.001; ns, not significant. (H) Lateral ventricles of P15
brains were analyzed by scanning electron microscopy in conditional double-Rfx2-Rfx3 deficient mice generated using the Foxj1-Cre strain. Compared to
control ependymal epithelia (left), a major reduction in the number of ciliated cells was observed in ependymal epithelia deficient for both Rfx2 and Rfx3
(right). Two representative images are shown for each genotype.
cantly affected compared to controls (Figure 1D, E). In
contrast, Rfx3−/− ependymal cells cultivated in vitro ex-
hibited impaired ciliogenesis (Figure 1D, G) (12), despite
the fact that no ciliary defects were observed in vivo (28)
(Figure 1C). Similarly, ex vivo Rfx2−/− ependymal cells ex-
hibited completely defective ciliogenesis (Figure 1D, F), de-
spite the presence of normal multiciliated cells in Rfx2−/−
mice in vivo (Figure 1B). Thus, RFX2 and RFX3 play non-
redundant roles in motile ciliogenesis under our in vitro cell
culture conditions, whereas they appear to compensate for
each-others absence in vivo.
To address the possibility that the roles of RFX2 and
RFX3 in directing ependymal cell ciliogenesis might be re-
dundant in vivo we studied the consequences of a combined
deletion of Rfx2 and Rfx3 in these cells. Cell-specific dele-
tion of floxed Rfx2 and Rfx3 alleles (Rfx2flox and Rfx3flox)
was induced by means of the Foxj1-Cre transgene (49). Ef-
ficient Cre-mediated recombination was confirmed by im-
munofluorescence analysis, which demonstrated that the
expression of RFX2 and RFX3 was effectively abolished
in ependymal cells (Supplementary Figure S2D). We ob-
served that the combined deletion of Rfx2 and Rfx3 led to
a marked impairment of ependymal cell ciliogenesis (Fig-
ure 1H). These results confirm that RFX2 and RFX3 in-
deed have redundant functions in ependymal ciliogenesis in
vivo. The same functional redundancy was also observed in
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vivo for airway ciliogenesis: whereas no defects in tracheal
cilia were observed at birth in Rfx3−/− pups (11) or adult
Rfx2−/− mice (46), we observed a significant reduction in
the number of multiciliated tracheal cells at birth when both
Rfx2 and Rfx3 were deleted (Supplementary Figure S2B
and C).
RFX1, RFX2 and RFX3 regulate common and specific gene
sets in ependymal cells
To understand how RFX1–3 exert their functions in
ependymal cells, we performed RNA-seq experiments with
ex vivo cultured ependymal cells obtained from E18.5 WT,
Rfx1−/−, Rfx2−/− and Rfx3−/− embryos. Global analysis
of differential gene expression was performed for each mu-
tant cell type relative to WT cells (Figure 2A). Genes were
considered to be differentially expressed if the fold-change
was >2 with a P-value of <0.001 (Supplementary Table
S1, genes indicated as down/up ‘high’; genes with a fold
change between 2 and 1.5 were also included in the table,
indicated as down/up ‘low’). Whereas 298 and 443 genes
were significantly down regulated >2 fold, respectively, in
Rfx2−/− or Rfx3−/− cells compared to WT cells, only 11
genes were down regulated in Rfx1−/− cells (Figure 2B).
Markedly fewer genes were up-regulated: 47 for Rfx2−/−,
116 for Rfx3−/− and only 2 for Rfx1−/− cells (Figure 2B).
There was no overlap between the differentially expressed
(DE) gene sets in Rfx1−/− cells and DE gene sets in Rfx2−/−
or Rfx3−/− cells (Figure 2B). Among upregulated genes,
only a minority was shared by Rfx2−/− (12/47 genes) and
Rfx3−/− (12/116 genes) cells (Figure 2B). In sharp contrast,
there was strong overlap between downregulated gene sets
in Rfx2−/− and Rfx3−/− cells: most genes downregulated
in Rfx2−/− cells were also downregulated in Rfx3−/− cells
(Figure 2B: 220/298 genes), and nearly half of the genes
downregulated in Rfx3−/− cells were also downregulated in
Rfx2−/− cells (220/443 genes). Interestingly, the genes that
were downregulated most strongly in Rfx3−/− cells were
nearly all downregulated as well in Rfx2−/− cells (Figure
2C, left), whereas the reverse was not true: only part of the
most strongly downregulated genes in Rfx2−/− cells was
also downregulated in Rfx3−/− cells (Figure 2C, right).
To determine if cross-regulation between different Rfx
genes could contribute to the observed overlap in downreg-
ulated genes between Rfx2−/− and Rfx3−/− cells, we quan-
tified the respective mRNA expression levels for Rfx1–3
genes in WT and the three Rfx-deficient ependymal cells.
Rfx1−/− and Rfx2−/− cells exhibited no significant reduc-
tions in expression of the other two Rfx mRNAs. However,
significant reductions in Rfx1 and Rfx2 expression were ob-
served in Rfx3−/− cells (Supplementary Figure S3). These
results suggest that deregulated expression in Rfx1−/− or
Rfx2−/− cells is a direct consequence of the deficiency in
RFX1 or RFX2, respectively. On the other hand, reduced
RFX2 expression could account in part for the observed
pattern of deregulated gene expression in Rfx3−/− cells. The
latter mechanism is likely to be particularly relevant for
genes that are downregulated in both Rfx2−/− and Rfx3−/−
cells.
Gene Ontology (GO) analyses were performed for gene
sets that were downregulated in Rfx2−/− and/or Rfx3−/−
ependymal cells. Gene sets that were downregulated in
Rfx3−/− cells alone or in both Rfx2−/− and Rfx3−/− cells
were significantly enriched in genes encompassed by GO
terms associated with cilium biogenesis or function (Sup-
plementary Figure S4A, Supplementary Table S2). GO
terms associated with microtubule-based processes and
movement were also significantly enriched, which could be
related to the regulation of ciliogenesis. No significant en-
richment for specific GO terms was found in the set of genes
that is downregulated only in Rfx2−/− cells (not shown).
To investigate further whether the downregulated gene
sets could be used to predict novel ciliary genes, we per-
formed gene set enrichment analyses (GSEA, (63)) for path-
ways associated with cilia assembly or function. The GSEA
analyses were performed with several different sets of ciliary
genes, including the previously defined Syscilia gold stan-
dard set of genes (set A) (62) and two sets comprising, re-
spectively, human ciliopathy associated genes (set B) or po-
tential ciliary genes identified on the basis of phenotypes
documented in animal models (set C, Supplementary Table
S3) (61). For all three gene sets, the distribution of ciliary
genes was strikingly shifted towards the most down regu-
lated genes in both Rfx2−/− and Rfx3−/− cells, indicating
that genes exhibiting reduced expression in these cells are
strongly enriched in functions associated with cilia assem-
bly and function (Supplementary Figure S4B). Similar re-
sults were obtained using other ciliary gene sets (data not
shown).
Genes regulated by RFX2 and RFX3 share indistinguishable
X-Box motifs
Two complementary strategies were used to identify poten-
tial DNA-binding motifs for RFX factors in the promoter-
proximal regions (defined here as −1000 to +500 bp relative
to the transcription start site, TSS) of genes that are down-
regulated in Rfx2−/− and/or Rfx3−/− ependymal cells. As a
first approach, Pscan software was used to quantify the en-
richment of known transcription factor binding site (TFBS)
motifs described in the JASPAR database. TFBS motifs
were clustered on the basis of their enrichment scores in
different downregulated gene sets, and results are presented
as a heatmap (Figure 3A, Supplementary Figure S5). This
analysis revealed that X-box motifs (TFBS motifs defined
for RFXs are presented in Figure 3B) are highly enriched
in the promoters of most subsets of genes downregulated
in Rfx2−/− and Rfx3−/− cells, with the exception of genes
regulated exclusively by RFX2 (Figure 3A, Supplementary
Figure S5). As a second unbiased approach, a de novo mo-
tif discovery method (cosmo package for R) was used to
identify motifs that are enriched in the promoters of differ-
ent sets of genes downregulated in Rfx2−/− and/or Rfx3−/−
cells (Figure 3C). Although applying this de novo search to
−1000 to +500 promoter regions did not give significant
results, using a more restricted promoter definition (−250
to +50) identified very similar motifs, all exhibiting nearly
perfect matches to the previously defined X-box, in most
subsets, with the exception of genes regulated by RFX2
alone. This motif discovery strategy revealed no differences
between the X-box signatures for different downregulated
gene subsets, as confirmed by TOMTOM (73) analysis of
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Figure 2. Analysis of differentially expressed genes in ependymal cells from Rfx1, Rfx2 or Rfx3 deficient mice. (A) The volcano plots represent statistical
significance (Y-axis, –log10 P-value) and fold change (X-axis, log2 fold change) for alterations in gene expression observed in Rfx1−/−, Rfx2−/− or Rfx3−/−
cells relative to WT cells. Whereas only few genes exhibited significantly altered expression in Rfx1−/− cells, numerous genes were differentially expressed
in Rfx2−/− and Rfx3−/− cells. (B) The Venn diagrams summarize the overlaps observed between up (left) or down (right) regulated gene sets (fold change
>2) in Rfx1−/−, Rfx2−/− or Rfx3−/− cells. Whereas there is little overlap between genes upregulated in Rfx2−/− and Rfx3−/− cells (left), most genes
downregulated in Rfx2−/− cells are also downregulated in Rfx3−/− cells (right). There is no overlap between genes that are differentially expressed in
Rfx1−/− cells and Rfx2−/− or Rfx3−/− cells. (C) The bar graphs show the fold changes in gene expression (log2 fold change) observed in Rfx2−/− (black
bars) and Rfx3−/− (grey bars) cells for the 30 genes that are downregulated most strongly in Rfx2−/− (left) or Rfx3−/− (right) ependymal cells. Whereas
nearly all genes that are strongly downregulated in Rfx2−/− cells are also strongly downregulated in Rfx3−/− cells (left), the reverse is not true (right).
Genes highlighted in blue contain at least one X-box motif in their promoter region (−1000 to +500 bp).
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Figure 3. Identification of TFBS motifs in the promoters of genes that are downregulated in Rfx2 and/or Rfx3 KO cells. The promoters (−1000 to +500
pb relative to the TSS) of different sets of downregulated genes were examined by two unbiased approaches for the presence of specific TFBS motifs.
(A) Selected region of a heatmap focusing on the most enriched motifs, determined using Pscan for the complete set of TFBS motifs from the JASPAR
database, in the promoters of the indicated sets of downregulated genes. The full heatmap is presented in Supplementary Figure S5. Colour key: blue,
under-represented motifs; yellow, over-represented motifs. In most gene sets examined, the most strongly enriched TFBS motifs were the X-box motifs
previously defined for RFX factors (the corresponding sequence logos are provided in (B)). Only promoters of genes that are downregulated exclusively in
Rfx2−/− cells did not exhibit an enrichment in these X-box motifs. (B) Sequence logos of RFX motifs from JASPAR database enriched in RFX-regulated
genes. (C) A de novo motif discovery approach (cosmo package) was applied to the promoters (−250 to +50 pb relative to the TSS) of the same sets of
downregulated genes. Typical X-box motifs were again revealed in the promoters of most sets of downregulated genes. As in (A) no motif resembling the
X-box was revealed in the promoters of genes downregulated only in Rfx2−/− cells. In the latter gene set, a G-rich motif was instead identified, which
could be related to the Egr1 motif (UP00007 1).
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the identified motifs, which demonstrated that all show the
best ranking value with the RFX1 MA0509.1 motif de-
fined in Figure 3B (Supplementary Table S4). This indicates
that differential target gene specificities of RFX2 and RFX3
cannot be accounted for simply by variations in the X-box
motif itself, or that such variations are subtle and not de-
tected by the analysis tools used here. For the set of genes
downregulated only in Rfx2−/− cells, a motif very different
from the X-box was identified. This motif is most closely re-
lated to UP00007 1, corresponding to the Egr1 motif. This
suggests that most of the genes that are downregulated in
Rfx2−/− cells are not regulated directly by RFX2, or that
RFX2 is recruited to enhancer regions situated far away
from their promoters.
The Pscan analysis was also performed for the promot-
ers of up-regulated genes, but this did not reveal any signifi-
cantly enriched RFX binding sites, suggesting that these up-
regulated genes could be indirect RFX targets. Interestingly,
several TFBS motifs were significantly enriched in genes
upregulated in the absence of RFX3 including, ZNF263,
MAZ, ZNF148, E2F6, SP1, E2F3, TFAP (Supplemental
Figure S5).
Altogether, these observations indicate that a significant
fraction of downregulated genes in Rfx2−/− and Rfx3−/−
ependymal cells are likely to be direct targets of either RFX3
alone or both RFX2 and RFX3.
RFX1-3 share numerous binding sites in mouse ependymal
cells
To identify genes that are regulated directly by RFX1,
RFX2 and/or RFX3 in ependymal cells, we performed
chromatin immunoprecipitation sequencing (ChIP-seq) ex-
periments for each transcription factor using ex-vivo cul-
tured ependymal cells from WT mice. Total numbers of
RFX occupied sites (ChIP-seq peaks) in the genome were
7440 for RFX1, 1250 for RFX2 and 9318 for RFX3. Sites
occupied by the three factors exhibited similar distributions
in promoter regions (defined here as −1000 to + 500 bp rel-
ative to the TSS), intergenic regions, introns and exons (Fig-
ure 4A). The peak distribution for each factor was centered
just upstream of the TSS (Figure 4B).
TFBS motif analysis was performed as described above.
The de novo motif discovery approach (cosmo package for
R) was performed for the 100 most robust peaks (based on
the number of sequence reads) for each RFX factor. For
each factor a clear X-box motif was identified (Figure 4C,
Supplementary Table S5). These motifs exhibited only mi-
nor differences between the three RFX factors, indicating
that the best 100 peaks for each RFX harbor a similar RFX
recognition sequence. It should be noted however, a signifi-
cant portion of the 100 most robust peak sets defined for the
three factors is shared between more than one RFX factor
(Supplementary Figure S6A). Furthermore, peak overlaps
are even greater when the top 100 peaks for each individual
RFX factor are compared with all peaks for the remain-
ing two factors (Supplementary Figure S6B). Therefore, to
favor the identification of potential differences in sequence
preference between RFX factors we performed the de novo
motif analysis on the 100 most robust peaks that are unique
to each RFX, using the least stringent window to identify
coinciding peaks, i.e. <500 bp spacing between peaks. This
strategy revealed nearly identical X-box motifs for RFX1
and RFX3 (Supplementary Figure S6C), indicating that no
RFX1 and RFX3 motif preference could be discriminated.
This analysis was not possible for RFX2, as only 10 of its
most robust peaks did not overlap with any RFX1 or RFX3
peaks, a number that is too low to perform a reliable de novo
motif analysis. A Pscan analysis was next performed on all
peaks using the newly identified X-box motifs and all TFBS
motifs described in the JASPAR database. For each RFX
factor the ten most enriched motifs included the newly iden-
tified RFX binding sites and TFBS motifs previously de-
fined for RFX2, RFX1 and RFX5 (Figure 4D, Supplemen-
tary Table S5), again indicating that the three RFX factors
bind very similar motifs. Thus, RFX binding-site specificity
or function does not seem to rely on readily detectable vari-
ations in their binding motifs.
Other predicted TFBS motifs were also found to be en-
riched in RFX ChIP-seq peaks. Close examination of these
motifs indicated that several show partial overlap with the
X-box (Figure 4D: MYB NFIC, NFIX, NFIB, YY2). How-
ever, a number of other significantly enriched motifs were
identified as well. 17 and 47 TFBS motifs were found to be
enriched specifically in ChIP-seq peak sets for RFX1 and
RFX3, respectively (Figure 4E, Supplementary Table S5),
suggesting that the corresponding factors could be RFX1
or RFX3 specific regulatory partners. Only three enriched
TFBS motifs were identified in the RFX2-specific ChIP-
seq peak set (FOSL1::JUND(VAR2); GMEB1; MYBL). A
number of enriched motifs were shared by ChIP-seq peak
sets defined for RFX1 and RFX3 (73 motifs) or all three
RFX factors (310 motifs). The latter includes the Y-box,
which is bound by NF-Y and is tightly associated with the
X-box in the promoters of MHC class II genes (74). NFY
is known to bind cooperatively with a transcription factor
complex containing RFX5, a process that is essential for
RFX5 function in antigen presenting cells (74). Thus, our
results suggest that a similar functional association of X and
Y-boxes could also be involved in the function of RFX1–3
in ependymal cells. The other enriched motifs found in RFX
common peaks could represent TFBS motifs for regulatory
partners of two or more RFX factors.
To identify genomic loci occupied by more than one RFX
factor, we compared the sets of ChIP-seq peaks obtained for
the three individual factors. Four different distance param-
eters were used to define coinciding peaks: two peaks were
considered to overlap if their centers were less than 15, 50,
100 or 500 bp apart. The analysis was done separately for
all peaks (Supplementary Figure S6D) or for peaks situated
in promoter regions (Figure 5). Using all four distance pa-
rameters, a major proportion of the total number of RFX-
bound loci were bound by more than one RFX factor. As
the size of the X-box motif is only 15 bp, the overlap anal-
ysis done using this distance parameter likely identifies sin-
gle binding sites bound by multiple factors. Increasing the
distance parameter to 50, 100 and 500 bp led to relatively
minor increases in the numbers of regions occupied by two
or three factors, suggesting either technical issues leading to
imprecise mapping of the same binding site or the presence
of several closely spaced binding sites. As overlap numbers
obtained with the 50, 100 and 500 bp distance parameters
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Figure 4. Identification of direct target genes and binding motifs for RFX1, RFX2 and RFX3. ChIP-seq was used to map genomic sites occupied by RFX1,
RFX2 and RFX3 in mouse ependymal cells. (A) The pie charts illustrate the distribution of sites occupied by RFX1, RFX2 and RFX3 in the indicated
portions of the genome. (B) The histograms represent the spatial distribution of RFX1, RFX2 and RFX3 occupied sites within promoter-proximal regions
(−2kb to +2kb) centered on annotated TSSs. (C) The sequences logos show the top scoring DNA motifs identified by de novo motif discovery analysis
(cosmo package) performed with the 100 most robust RFX1, RFX2 or RFX3 ChIP-seq peaks. All three motifs perfectly match the X-box motifs described
in Figure 3B. (D) Sequence logos are shown for most enriched TFBS motifs identified using Pscan in ChIP-seq peaks for RFX1, RFX2 or RFX3. Only the
5 top ranking RFX motifs and non-RFX motifs are represented. The scan was done with all TFBS motifs from the JASPAR database. The de novo motifs
(red) identified in (C) were included in the scan and are among the five best motifs. P-values are indicated in parentheses: values <1.0E–300 were rounded
off to 0. The full list of motifs and P-values for their enrichment are provided in Supplementary Table S5. (E) The Venn diagrams show the overlap between
sets of DNA motifs, distinct from the X-box, identified in regions bound by RFX1, RFX2 or RFX3 (see Supplementary Table S5). Certain motifs appear
to be specifically enriched in RFX1 (17 motifs) or RFX3 (47 motifs) occupied regions. A significant number of other motifs are found in regions bound
by both RFX1 and RFX3 (73 motifs) or by all three RFX factors (310 motifs).
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Figure 5. Overlap between sets of promoters occupied by RFX1, RFX2 and/or RFX3. The Venn diagrams illustrate the overlap between sites (situated
between −1000 to +500 bp relative to the TSS) occupied by RFX1, RFX2 and/or RFX3. Sites were scored as being co-occupied by two or three RFX
factors when the distance between their ChIP-seq peak centers were <15, <50, <100 or <500 bp. In most cases, the centers of ChIP-seq peaks at co-
occupied promoters were situated <15 pb apart, which is less than the size of the X-box motif, indicating that RFX1, RFX2 and/or RFX3 are bound to
the same binding site at these promoters. At a minority of co-occupied promoters, the centers of ChIP-seq peaks were separated by between 15 and 500
bp, suggesting the potential presence of 2–3 closely spaced binding sites.
were very similar to each other, it is likely that the majority
of regions occupied by multiple RFX factors contain either
only a single binding site or 2–3 very closely spaced (<50
bp) binding sites. Lists of promoters occupied by single or
multiple RFX factors are provided in Supplementary Table
S6.
Many RFX target genes are involved in cilia assembly or func-
tion in ependymal cells
A GO analysis was first performed using Panther (68) for
gene sets having promoter regions bound by RFX1, RFX2
or RFX3 (Supplementary Table S7, Supplementary Figure
S7). Most significantly enriched GO terms for biological
functions defined for RFX1, RFX2 and RFX3 ChIP targets
were found to be related to cilia, indicating that each factor
binds preferentially to promoters of genes implicated in cilia
assembly or function. Enriched GO terms also included mi-
crotubule or centrosome associated processes, which could
be related to the regulation of ciliogenesis. Lastly, the en-
riched terms indicated an association with regulation of the
cell cycle, in agreement with tight coupling between cilio-
genesis and control of the cell cycle. Curiously, the set of
RFX3 targets is also highly enriched in genes involved in
mitochondrial respiratory chain assembly.
We also performed GO enrichment analyses for all ChIP-
seq Peaks using GREAT analysis (75) to assign peaks to
specific genes (Supplementary Table S8). Among the GO
terms associated with biological processes (Supplementary
Table S8), the top ranking GO terms are linked to cilia and
cell cycle associated functions. Collectively, these analyses
indicate that genes that are potentially regulated by RFX1–
3 through promoters or distal enhancers are highly enriched
in genes involved in cilia related functions. Lastly, RFX1
and RFX3 target genes are also associated with GO terms
related to metabolic processes.
We next crossed our expression data for Rfx2−/− and
Rfx3−/− cells with our RFX ChIP-seq data for the three
RFX factors to identify genes that are regulated directly
by RFX factors in ependymal cells (Figure 6, Supple-
mentary Table S9). Approximately half (45–56%) of the
down-regulated genes, and nearly all up-regulated genes,
were found to lack RFX-bound sites in their promoters.
When examining both distal enhancers and promoters us-
ing GREAT analysis, 15–21% of down-regulated genes and
22–48% of up-regulated genes were found to lack RFX-
occupied sites in their regulatory sequences (Supplementary
Figure S8). These results suggest that a substantial portion
of differentially related genes are likely to be indirect targets
of RFX factors in ependymal cells. Alternatively, they could
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article/48/16/9019/5877810 by W
ashington U
niversity, Law
 School Library user on 24 O
ctober 2020
9030 Nucleic Acids Research, 2020, Vol. 48, No. 16
A
B
C D
Figure 6. Identification of RFX target genes. (A) The pie charts show the fractions (%) of genes that are downregulated (top) or upregulated (bottom) in
Rfx2−/− cells (left), Rfx3−/− cells (middle) or both (right) and have ChIP-seq peaks for RFX1, RFX2 and/or RFX3 within their promoters. Approximately
one-third of downregulated genes have binding sites for either RFX1 plus RFX3 or all three RFX factors in their promoters. A minority of downregulated
genes have binding sites for only RFX1 or RFX3. No downregulated genes are occupied by RFX2 alone. Most genes upregulated in Rfx2−/− or Rfx3−/−
cells alone, and all genes upregulated in both Rfx2−/− and Rfx3−/− cells, lack RFX-occupied sites in their promoters. (B) Gene set enrichment analysis
(GSEA) demonstrates that genes having RFX1, RFX2 or RFX3 ChIP-seq peaks in their promoters are strongly enriched in genes that are differentially
expressed in Rfx2−/− or Rfx3−/− cells. (C, D) Histograms show the fold change (log2 FC) in expression for genes that are downregulated >2 fold in
Rfx2−/− (light grey) or Rfx3−/− cells (dark grey). The presence of RFX1, RFX2 and/or RFX3 ChIP-seq peaks in the promoter is indicated for each gene
at the right. (D) As in C, focusing on genes that are downregulated in both Rfx2−/− and Rfx3−/− cells, and have promoters occupied by all three RFX
factors. All of these genes have at least one X-box motif in their promoter (−1000 to +500 bp), as highlighted by the blue font.
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be controlled by distal RFX-regulated enhancers that are
difficult to correctly assign to a single gene. Among down-
regulated genes with RFX occupied sites in their promoters
or putative distal enhancers, most were bound by at least
two RFX factors––either all three RFX factors or RFX1
plus RFX3––whereas only a minority were bound by RFX3
or RFX1 alone, and none were bound by RFX2 alone or
RFX2 plus RFX3 (Figure 6A, Supplementary Figure S8).
We also performed a GSEA analysis of sets of genes con-
taining RFX1, RFX2 or RFX3 occupied sites in their pro-
moters in the expression data obtained for Rfx2−/− and
Rfx3−/− cells (Figure 6B). We observed a strong enrichment
of RFX-occupied promoters in downregulated genes, indi-
cating a strong correlation between the occupancy of pro-
moters by RFX proteins and their transcriptional regula-
tion by RFX2 and/or RFX3.
A set of high-confidence RFX targets genes - namely
the 28 genes that are downregulated in both Rfx2−/−
and Rfx3−/− cells, and have promoters occupied by all
three RFX factors - were examined for the presence
of genes related to cilia (Figure 6C). Most (21/28) of
these genes have been shown to be involved in cilio-
genesis (Spata18, Rsph14, Hydin, Wdr65/Cfap57, Lrrc6,
Lrrc34, Dnaaf1, Lrrc23, Saxo2/Fam154b, Dlec1, Cfap221,
Wdr16/CFAP52, Cep128, Ccdc65, Rsph10b, march10) or to
be highly expressed in ciliated tissues (Cfap161, Ccdc146,
Ccdc108/Cfap65, Cfap74, Lrrc46). The remaining 7 genes
(Fhad1, E230008N13Rik/ccdc180, Tsnaxip1, Casc1, Kif6,
Zswim2, Serpinb1b) have not been previously associated
with cilia. However, given their tight coregulation with
other cilia-related genes, they are excellent candidates for
having novel ciliary functions. A similar analysis done for
downregulated genes exhibiting a fold change situated be-
tween –2 and –1.5 (Supplementary Figure S9) also high-
lighted a strong enrichment in genes associated with ciliary
function in the set of direct RFX1–3 targets, thus provid-
ing further interesting ciliary candidates. Finally, we inves-
tigated whether genes linked to ciliopathies (187 mouse or-
thologs of genes from (61)) are direct RFX targets. Many
of these genes are indeed bound by at least one RFX factor
and/or are downregulated in Rfx2−/− and/or Rfx3−/− cells
(Figure 7, Supplementary Table S9). In particular, the ex-
pression of all genes involved in primary ciliary dyskinesia
are regulated by RFX2, RFX3 or both in ependymal cells,
and most of these are direct RFX targets. In conclusion,
our observations illustrate the critical role played by RFX2
and RFX3 in the motile ciliogenesis program in mice, and
suggest that there are likely to be novel, previously uniden-
tified, cilia-associated genes among the direct RFX target
genes we have identified.
DISCUSSION
We show here that RFX2 and RFX3 have both redun-
dant and specific functions in the biogenesis of motile cilia
on mouse ependymal cells, whereas RFX1 does not seem
to play a key regulatory role in this process. This is sup-
ported by the ependymal phenotypes of Rfx1, Rfx2 and
Rfx3 single-knockout mice, and of conditional Rfx2:Rfx3
double-knockout mice, as well as by the analysis of direct
and indirect targets of RFX1, RFX2 and RFX3 in ependy-
mal cells. We demonstrate that many direct targets of RFX2
and RFX3 are known to be involved in cilia assembly or
function, and furthermore provide valuable lists of new can-
didate ciliary genes. Our results also reveal complex com-
pensatory mechanisms operating at the cellular level, as re-
vealed by the phenotypic differences observed between in
vivo ventricular ependymocytes and the corresponding in
vitro differentiated cells. Compensatory mechanisms also
appear to be operating at the molecular level, as revealed
by the uncoupling between genome occupancy by RFX1
and genes effectively regulated by RFX1 versus the strong
correlation observed between genome occupancy and gene
expression for RFX2 and/or RFX3.
The promoters of numerous genes that are downregu-
lated in Rfx2−/− or Rfx3−/− ependymal cells are actually
occupied by these transcription factors in these cells, con-
firming that they are direct RFX targets. However, we found
that a substantial portion of the deregulated genes do not
show binding of RFX2 or RFX3 in their promoter regions
or distal enhancers as assigned by GREAT analysis, sug-
gesting that they could be indirect RFX targets. Alterna-
tively, these genes could be regulated by binding of RFX2
or RFX3 at distant enhancers, which would be consistent
with the finding that less than a third of all RFX ChIP-
seq peaks are actually localized in promoter regions. The
mechanisms by which RFX factors activate transcription
is poorly understood. In C. elegans, most target genes are
regulated by binding of RFX to sites situated close to the
TSS (44,76). In mouse lymphocytes, RFX1 regulates chro-
matin modification at the IL17 promoter (37). The most
thorough understanding comes from studies in xenopus, in
which RFX2 was shown to act both at distant chromatin
loci and at promoter sites, and to be involved in chromatin
looping to stabilize FoxJ1 (14). Such long-range chromatin
organizing functions could also be acting in ependymal cells
for RFX2 and RFX3, and this could account for the regula-
tion of specific subsets of genes lacking RFX-occupied sites
in their promoters. Chromatin-conformation analysis stud-
ies will be necessary to understand further how RFX2 and
RFX3 control target gene expression.
Motif discovery analyses of our ChIP-seq and RNA-seq
data sets did not reveal any significant differences between
the X-box motifs for RFX1, RFX2 and RFX3. Yet these
transcription factors occupy distinct, albeit overlapping,
sets of genomic loci. This may reflect inherent limitations in
the motif discovery algorithms that were used, which could
be insufficiently sensitive to reveal subtle differences. Al-
ternatively, RFX1, RFX2 and RFX3 target site specificity
could rely on associated promoter or enhancer binding sites
for other transcription factors. Our de novo motif discovery
approach did not reveal specific sequence motifs linked to
the X-box in RFX1–3 target genes, indicating that potential
associated motifs are more diverse or less well defined than
the X-box motif. However, motif discovery analyses using
Pscan did allow us to identify a number of transcription
factor motifs enriched selectively in promoters occupied by
RFX1–3 proteins. Certain of these motifs are specific for
RFX1 or RFX3 occupied regions. TFs binding to these as-
sociated motifs could be responsible for determining differ-
ential occupancy by the RFX factors, and thus explain why,
despite their identical X-box motifs, RFX1 and RFX3 oc-
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Figure 7. Many ciliopathy genes are direct targets of RFX1, RFX2 and/or RFX3. The histograms show the fold change in expression (log2 FC) in Rfx2−/−
and Rfx3−/− cells for 187 mouse orthologs of genes that are affected in human ciliopathies. The presence RFX1, RFX2 and/or RFX3 ChIP-seq peaks
in their promoters is indicated at the right. Significant reductions in gene expression are highlighted in light (Rfx3−/− cells) or dark (Rfx2−/− cells) grey,
whereas non-significant variations are indicated in orange (Rfx3−/− cells). Genes highlighted in red are orthologs of human genes implicated in Primary
Ciliary Dyskinesia (PCD). Nearly all of these PCD genes are direct targets of RFX1, RFX2 and/or RFX3, and are downregulated significantly in Rfx2−/−
and/or Rfx3−/− cells. All genes have at least one X-box motif in their promoter, except for those indicated in black font.
cupy different sets of loci in ependymal cells. In addition,
occupancy by RFX1 and RFX3 could rely on binding of
factors to distant regions, or be sensitive to particular chro-
matin configurations that our study have not addressed.
We identified 310 transcription factor binding motifs that
are enriched in promoters of genes bound by all three tran-
scription factors. Many of these have binding sites that over-
lap with or resemble RFX motifs. However enriched motifs
that are clearly distinct from RFX motifs include those for
members of the E2F family of transcription factors (E2F4,
E2F1, E2F3, E2F6). Interestingly, E2F4 and E2F5 have
been shown to be involved in regulating ciliogenesis in the
mouse, zebrafish or C. elegans, and E2F transcription fac-
tors associate with Geminin or multicilin to regulate cili-
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ogenesis (20, 77–80). E2F transcription factors have also
been shown to be involved in cell cycle regulation, which
is in agreement with the tight link beween ciliogenesis and
cell cycle control. Together with our observations, this in-
dicates that E2F family members are likely to collaborate
with RFX transcription factors to regulate ciliary gene ex-
pression. Two other transcription factors for which binding
motifs are enriched in direct target genes of RFX1–3 are
ZFP423/ZNF423 and ATOH (Supplementary Table S5).
ZFP423 has been shown to regulate primary cilia formation
and 12 genes involved in ciliogenesis were found to be regu-
lated by ZFP423, including Tulp3, which was confirmed to
be a direct target of ZFP423 (81). We show here that Tulp3
is also a direct target of RFX1–3, suggesting functional in-
teractions between ZFP423 and RFX factors in the control
of ciliogenesis. ATOH belongs to the family of proneural
factors involved, in particular, in hair cell maintenance (14–
16). The fly ortholog, atonal, has been shown to regulate
Drosophila RFX genes as well as ciliary genes (82). This in-
dicates that evolutionary conserved regulatory networks in
ciliogenesis involve RFX and the atonal proneural factors.
Collectively, these observations suggest that ciliary gene ex-
pression is regulated by complex transcription factor net-
works. Deciphering these complex networks will be a chal-
lenging endeavor.
Although RFX1 binds to numerous loci in ependymal
cells, it does not appear to have a major impact on gene ex-
pression in these cells, and a deficiency in RFX1 does not
lead to overt ciliary phenotypes in multiciliated epithelia.
As each of the three RFX factors can form homodimers
and heterodimers, it is likely that RFX1 homodimers as
well as heterodimers with RFX2 and/or RFX3 can occupy
regulatory regions containing X box motifs. However, our
data suggests that RFX1 homodimers and heterodimers
could be less efficient at activating transcription than RFX2
and RFX3 homodimers or heterodimers. Hence, removing
RFX1 alone would not be sufficient to observe a major con-
sequence on gene expression. These considerations further
raise the question of whether or not RFX1 actually has
any function in ciliogenesis. We have observed that the dele-
tion of Rfx1 in conjunction with Rfx3 is highly deleterious
during embryogenesis, leading to early embryonic lethality
between E9 and E10 (data not shown). We have been un-
able to relate this lethality to evident defects in ciliogenesis
in the early embryonic tissues that we have analyzed (pri-
mary cilia of the neural tube or mesenchymal cells, data not
shown). We did also not observe clear defects in ciliogenesis
in ependymal cells by a combined conditional deletion of
RFX1 and RFX3 using the FoxJ1-cre deleter strain (data
not shown). Thus, although we cannot fully exclude that
RFX1 could have cilia-related functions during develop-
ment, our data suggests that embryonic lethality induced by
the combined deletion of Rfx1 and Rfx3 could well be due
to the regulation of other pathways. In this respect, it should
be mentioned that in yeast or fungi, RFX factors have been
implicated in regulation of the cell cycle and genome re-
pair (83–86). Defects in such pathways could also account
for embryonic lethality observed in the double mutants. We
identified >1400 genes which can potentially be regulated
directly by RFX1 and RFX3 (Figure 2) and GO classifica-
tion of these genes indicate that, in addition to ciliary genes,
several could be essential for development, such as genes in-
volved in assembly of the mitochondrial respiratory chain
complex, in the assembly of ribonucleoprotein complexes,
or in cell cycle progression. These target genes could explain
the essential role played by RFX1 together with RFX3 in
mouse embryonic development.
Here, we have identified RFX1, RFX2 and RFX3 target
genes in ependymal cells. In a previous study, we analyzed
RFX1 and RFX3 target genes by ChIP-seq (47) in a pancre-
atic -cell line (Min6) because Rfx3 deficient mice showed
impaired pancreatic development (60,72) associated with
impaired primary cilia formation. We also previously iden-
tified RFX2 targets by Chip-seq and RNA-seq in the testis,
where RFX2 is required for spermatid differentiation (46).
Comparisons between the sets of target genes in these three
different tissues demonstrated partial overlaps (Supplemen-
tary Table S10, Supplementary Figure S10). Common tar-
gets in the different cell types are significantly enriched in
ciliogenic genes (Supplementary Table S11). Interestingly,
GO analysis of tissue specific targets showed that genes reg-
ulated by RFX1 or RFX3 exclusively in Min6 cells are not
associated with ciliogenesis, whereas target genes regulated
directly by RFX1, 2 or 3 in ependymal cells are enriched in
GO terms associated with cilia or microtubule-based pro-
cesses. These observations indicate that RFX transcription
factors regulate a core set of genes associated with cilio-
genesis in all tissues, but that RFX1 or RFX3 could also
play specific regulatory roles distinct from ciliogenesis in
Min6 cells. By contrast, all sets of RFX2 target genes iden-
tified here are associated with ciliogenesis, indicating a fo-
cused function of RFX2 in this biological function. This is
in agreement with observations made in other vertebrates,
where RFX2 plays a prevalent role in the motile ciliogenesis
program (13,14,30).
Our work reveals redundant roles of RFX2 and RFX3 in
the mouse, as well as surprising differences between com-
pensatory mechanisms operating in the in vivo and in vitro
differentiation processes of ependymal cells. Whereas re-
moval of either RFX2 or RFX3 alone leads to multicil-
iated cell differentiation defects in vitro, only removal of
both factors leads to ependymal defects in vivo. Although
we do not as yet have any molecular explanations for this
observation, a number of potential mechanisms could be at
play. One major difference between the in vivo setting and
the ex-vivo model is the spatio-temporal regulation of cell
differentiation in a complex tissue in vivo. Ependymal cell
differentiation is governed in vivo by finely tuned develop-
mental cues, which are communicated to specific cells in a
well-defined spatially and temporally controlled pattern. In
sharp contrast, the ex vivo differentiation program is trig-
gered by serum deprivation, which affects all cells in the cul-
ture at the same time. These differences could allow for com-
pensatory regulatory pathways to be recruited in vivo but
not in vitro. One might consequently question the biolog-
ical relevance of the RNA-seq and ChiP-seq experiments,
which were both performed using the in vitro differentiation
model. However, as redundancy between RFX2 and RFX3
was observed at the levels of both their biochemical proper-
ties in vitro and their developmental functions in vivo, the in
vitro data reported here are consistent with the in vivo roles
of RFX3 and RFX2.
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Similar redundancies between RFX factors need to be
considered in other organisms, particularly in humans,
where the functions of RFX1–3 remain unknown. Together
with our observations, analyses of RFX expression patterns
and the presence X-box motifs in the human genome should
provide a valuable basis for furthering our understanding of
the functions of RFX1–3 in man (87).
Our observations reveal a central role of RFX2 and
RFX3 in the biogenesis of motile cilia and we therefore an-
ticipate that the target gene sets we have identified are highly
likely to include novel candidates implicated in ciliogenesis.
In particular, we expect to find key candidates among genes
that exhibit robustly reduced expression in Rfx2 and Rfx3
deficient ependymal cells and contain RFX2 and/or RFX3
occupied sites in their promoters and/or distal enhancers.
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45. Laurençon,A., Dubruille,R., Efimenko,E., Grenier,G., Bissett,R.,
Cortier,E., Rolland,V., Swoboda,P. and Durand,B. (2007)
Identification of novel regulatory factor X (RFX) target genes by
comparative genomics in Drosophila species. Genome Biol., 8, R195.
46. Kistler,W.S., Baas,D., Lemeille,S., Paschaki,M., Seguı́n-Estévez,Q.,
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